SOHO Highlights: State of the Art and Next Questions


 

ECHELON-1 Data on Brentuximab Vedotin for Frontline Advanced cHL: Examining A+AVD vs. ABVD

292 views
February 23, 2021
Comments 0
Login to view comments. Click here to Login